Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients

This publication has 20 references indexed in Scilit:

• New Vitamin D Analogs
  Seminars in Dialysis, 2001
• New analogs of vitamin D3
  Kidney International, 1999
• A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content
  American Journal of Kidney Diseases, 1997
• Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism
  American Journal of Kidney Diseases, 1996
• Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients
  Pediatric Nephrology, 1996
• Pathogenesis of secondary hyperparathyroidism
  Nephrology Dialysis Transplantation, 1996
• A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia
  American Journal of Kidney Diseases, 1995
• Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients
  Kidney International, 1992
• Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal Failure
  New England Journal of Medicine, 1989
• Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
  Journal of Clinical Investigation, 1984